Most Recent
IVF provider Virtus Health would be “the author of its own fate” if its proposed acquisition of rival Adora Fertility flopped, a judge has said in hearing the ACCC’s bid for a temporary injunction blocking completion of the planned purchase.
The ACCC has won an interim injunction blocking IVF provider Virtus Health from completing its purchase of rival Adora Fertility on Friday.
The competition regulator has filed court action seeking an injunction to stop Virtus Health from completing the purchase of rival Adora Fertility on Friday while a merger review is still in progress.
Danish drug maker Lundbeck has told the High Court it did not contract away a royalty-free licence to generic drug maker Sandoz to sell blockbuster antidepressant Lexapro, saying such a decision would be commercial “madness”.
Health tech giant Philips Electronics has been hit with a class action on behalf of consumers who say they have suffered injury and economic loss from using sleep apnea machines with an alleged safety defect that caused them to inhale dangerous chemicals and degrading foam particles.
Health experts have told a court hearing a challenge to a requirement that certain workers get the COVID-19 jab that vaccinations are an effective tool in the fight against the coronavirus, despite the global surge of ‘breakthrough’ infections caused by the outbreak of the highly-infectious Delta strain.
A judge has ruled legal challenges to orders requiring COVID-19 vaccines for certain workers in New South Wales are not exceptional enough to warrant the disclosure of cabinet documents, with the judge noting he did not think the state health minister's orders made vaccines "mandatory".
An appellate panel of the Fair Work Commission has upheld an aged care worker's termination for refusing a flu vaccine, but a full-throttled dissent by one commissioner warns Australians against "a system of medical apartheid and segregation".
NSW Health wants to amend its defence to an underpayments class action on behalf of 24,000 junior doctors, bringing claims that the lead applicant is barred from seeking compensation for group members under industrial relations law.
Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.